{"id":49748,"date":"2026-04-24T10:46:59","date_gmt":"2026-04-24T10:46:59","guid":{"rendered":"https:\/\/flamenet.io\/2026\/04\/24\/arrowhead-pharmaceuticals-receives-positive-chmp-opinion-recommending-approval-of-redemplo-plozasiran-to-reduce-triglycerides-in-adults-with-familial-chylomicronemia-syndrome-fcs-in-europe\/"},"modified":"2026-04-24T10:46:59","modified_gmt":"2026-04-24T10:46:59","slug":"arrowhead-pharmaceuticals-receives-positive-chmp-opinion-recommending-approval-of-redemplo-plozasiran-to-reduce-triglycerides-in-adults-with-familial-chylomicronemia-syndrome-fcs-in-europe","status":"publish","type":"post","link":"https:\/\/flamenet.io\/2026\/04\/24\/arrowhead-pharmaceuticals-receives-positive-chmp-opinion-recommending-approval-of-redemplo-plozasiran-to-reduce-triglycerides-in-adults-with-familial-chylomicronemia-syndrome-fcs-in-europe\/","title":{"rendered":"Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO\u00ae (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe &#8211; Arrowhead Pharmaceuticals, Inc."},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMivwFBVV95cUxPd1BkYk9GRG5oLU84SW5CSXhRZ0pHTFo1SGVzSWJiVXNsNWN1WGt5V0YxT3d5UnFKWWV4b3RmNHd6OGNOYnc3RmNGMWVDdWlrVldJNzZTYmNuSzJQUGdrSVJrR0U2ajZjNWV0VG1NNUJtQ3JtakNLMm5yVm1YY2NuZW5pSFIzLVMyaER3RC1rdEFIV0stVEZrYnE2UTIxS0d3NEMyWmhtVHpnN1VUSWp5NzN4MnduMVJUUXJrcVc3OA?oc=5\" target=\"_blank\">Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO\u00ae (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Arrowhead Pharmaceuticals, Inc.<\/font><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO\u00ae (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe&nbsp;&nbsp;Arrowhead Pharmaceuticals, Inc.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68],"tags":[],"class_list":["post-49748","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/49748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/comments?post=49748"}],"version-history":[{"count":0,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/49748\/revisions"}],"wp:attachment":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/media?parent=49748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/categories?post=49748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/tags?post=49748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}